Skip to main content
Equibles
INBP logo

INBP · Integrated Biopharma Inc · Metrics

Track INBP — free

Use INBP with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INBP.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.18 At close · Oct 15
Rebalance outlook locked
Market Cap
$5.59M
Shares
31.06M
Volume · Oct 15 600 Avg daily vol (3M) 13.72K

INBP metrics

83 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.18
Market cap
$5.59M

Price action

20 metrics
Price change (1W)
-2.7%
Price change (30D)
-1.2%
Price change (3M)
+5.9%
Price change (6M)
-35.7%
Price change (YTD)
-50.0%
Price change (1Y)
-41.9%
Trailing year
Price change (5Y)
-83.5%
52-week high
$0.38
52-week low
$0.15
Change from 52-week high
-52.6%
Change from 52-week low
+20.0%
Annualized volatility
78.3%
Annualized volatility (3M)
—
Beta
-0.4
RSI (14D)
50.6
Price vs SMA 50
+4.6%
Price vs SMA 200
-30.5%
Avg volume (3M)
13,722
Relative volume
0.0
Average dollar volume
$2,365

Company

3 metrics
Sector
Consumer Defensive
Industry
Packaged Foods
Shares outstanding
31.06M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.1×
reciprocal yield 784.7%
P / book
0.3
reciprocal yield 316.0%
FCF yield
16.0%
TTM · current market cap
Buyback yield
—
P / FCF
6.2
reciprocal yield 16.0%
P / operating cash flow
4.5
reciprocal yield 22.2%
Earnings yield
-50.8%

Historical valuation

8 metrics
P / E historical average (3Y)
10.7×
reciprocal yield 9.4%
P / E historical average (5Y)
7.0×
reciprocal yield 14.3%
EV / revenue historical average (3Y)
0.1×
reciprocal yield 764.7%
EV / revenue historical average (5Y)
0.3×
reciprocal yield 389.6%
EV / EBIT historical average (3Y)
29.1×
reciprocal yield 3.4%
EV / EBIT historical average (5Y)
19.5×
reciprocal yield 5.1%
EV / EBITDA historical average (3Y)
7.9×
reciprocal yield 12.6%
EV / EBITDA historical average (5Y)
7.0×
reciprocal yield 14.2%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
1.8%
Operating margin
-6.2%
Trailing 12 months
Net margin
-6.5%
Gross profit (TTM)
$800,000
Operating profit (TTM)
−$2.71M
Net income (TTM)
−$2.84M
Trailing 12 months
Diluted EPS (TTM)
$-0.09
FCF margin
2.0%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$1.41
Gross profit per diluted share (TTM)
$0.03
Operating profit per diluted share (TTM)
$-0.09
EBITDA per diluted share (TTM)
$-0.08
Net income per diluted share (TTM)
$-0.09
Operating cash flow per diluted share (TTM)
$0.04
Free cash flow per diluted share (TTM)
$0.03
Capital expenditures per diluted share (TTM)
$0.01
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.01
Book value per share
$0.57

Growth

11 metrics
Revenue growth YoY
-30.9%
Year over year
Net income growth YoY
-451.7%
Revenue (TTM)
$43.87M
Trailing 12 months
EPS growth YoY
-400.0%
Shares change YoY
-1.4%
Year over year · fewer shares
Revenue CAGR (3Y)
-4.7%
Revenue CAGR (5Y)
-7.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-7.1%
FCF CAGR (5Y)
-20.1%

Quality

14 metrics
Return on equity
-16.1%
Return on assets
-11.2%
Debt / equity
—
Current ratio
3.0
EBITDA (TTM)
−$2.41M
Free cash flow (TTM)
$895,000
Quick ratio
1.4
Interest coverage
-225.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$4.47M
Total assets
$25.34M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.24M
Capital expenditures (TTM)
$346,000
R&D (TTM)
—
SG&A (TTM)
$3.50M
Stock compensation (TTM)
$192,000
R&D / revenue
—
Stock compensation / revenue
0.4%

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
36 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1016504 Visit website Investor relations